Trials / Unknown
UnknownNCT01956201
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin in Mixed Hypercholesterolemic Patient: Multi Center, Randomized, Double-blind, Parallel-group, Therapeutic Confirmatory Study.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 476 (estimated)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Atorvastatin and Fenofibrate compared with atorvastatin monotherapy in mixed hypercholesterolemic patients.
Detailed description
Multi center, randomized, double-blind, parallel-group, therapeutic confirmatory study Primary Outcome Measure: The mean percent change of Non-HDL Cholesterol \[Time Frame: from baseline at week 8\] Secondary Outcome Measures: The achievement rate of LDL-C\<100mg/dl, Non-HDL-C\<130mg/dl \[Time Frame: from baseline at week 8\] The mean percent change of LDL-C, HDL-C, TG, TC, Apo-AI, Apo-B \[Time Frame: from baseline at week 4, 8\] The mean percent change of Non-LDL-C/HDL-C, TC/HDL-C, LDL-C/HDL-C, Apo-B/Apo-AI \[Time Frame: from baseline at week 4, 8\] The mean percent change of Fibrinogen, hs-CRP \[Time Frame: from baseline at week 4, 8\] Safety evaluation \[Time Frame: Treatment period and Extension period\]
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin 20mg | \[Atorvastatin Run-in Period\] Take Atorvastatin 20mg 1 tablet once a day (after breakfast) \[Treatment Period\] Take Atrovastatin 20mg/Fenofibrate 160mg or Atorvastiatin 20mg/Placebo of Finofibrate 160mg 2 tablet once a day (after breakfast) \[Extension Period\] Take Atrovastatin 20mg, Fenofibrate 160mg 2 tablet once a day (after breakfast) |
| DRUG | Fenofibrate 160mg | Refer to Intervention Description of Atorvastatin 20mg |
| OTHER | Placebo (Fenofibrate 160 mg) | Refer to Intervention Description of Atorvastatin 20mg |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2013-10-08
- Last updated
- 2015-02-04
Locations
30 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01956201. Inclusion in this directory is not an endorsement.